Fast-Tracking Drug Approvals: New Testing Protocol Unveiled is drawing significant interest across the industry.
The government has expedited the drug approval process by allowing immediate laboratory testing post-application, bypassing preliminary scrutiny. The Central Drugs Standard Control Organization's new protocol mandates companies submit finalized specifications based on pharmacopoeial standards. Technical scrutiny will be deferred, with potential re-testing if specifications are revised.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →